B-Cell Receptor-Associated Protein 29 (BCAP29) (Middle Region) Peptide
BCAP29
Reactivity: Human
Host: Synthetic
BP, WB
-
- Target See all BCAP29 products
- BCAP29 (B-Cell Receptor-Associated Protein 29 (BCAP29))
- Protein Region
- Middle Region
- Origin
- Human
-
Source
- Synthetic
- Application
- Blocking Peptide (BP), Western Blotting (WB)
- Characteristics
- This is a synthetic peptide designed for use in combination with anti-BCAP29 antibody (Catalog #: ARP44557_P050). It may block above mentioned antibody from binding to its target protein in western blot and/or immunohistochecmistry under proper experimental settings. There is no guarantee for its use in other applications.
- Purification
- Purified
-
-
- Application Notes
- Each Investigator should determine their own optimal working dilution for specific applications.
- Restrictions
- For Research Use only
-
- Format
- Lyophilized
- Reconstitution
- Add 100 μL of sterile PBS. Final peptide concentration is 1 mg/mL in PBS.
- Concentration
- 1 mg/mL
- Buffer
- Final peptide concentration is 1 mg/mL in PBS.
- Handling Advice
- Avoid repeated freeze-thaw cycles.
- Storage
- -20 °C
- Storage Comment
- For longer periods of storage, store at -20°C. Avoid repeat freeze-thaw cycles.
-
- Target
- BCAP29 (B-Cell Receptor-Associated Protein 29 (BCAP29))
- Synonyms
- AW208404 Peptide, Bap29 Peptide, BAP29 Peptide, B-cell receptor associated protein 29 Peptide, B cell receptor associated protein 29 Peptide, B-cell receptor-associated protein 29 Peptide, BCAP29 Peptide, Bcap29 Peptide
- Background
-
BCAP29 may play a role in anterograde transport of membrane proteins from the endoplasmic reticulum to the Golgi. BCAP29 may be involved in CASP8-mediated apoptosis.
Alias Symbols: BAP29, DKFZp686M2086
Protein Interaction Partner: BCAP31,PDXDC1,BCAP31
Protein Size: 337 - Molecular Weight
- 39 kDa
- Gene ID
- 55973
- NCBI Accession
- NM_001008406, NP_001008406
- UniProt
- A6NCU1
-
You are here:
